Mifepristone

ATP binding cassette subfamily B member 1 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33828996 Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. 2021 1
2 33123485 Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. 2020 3
3 22570346 Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane X receptor. 2012 Jun 8 1
4 18703021 Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84). 2008 Oct 1 1
5 17131043 Progesterone-dependent and -independent expression of the multidrug resistance type I gene in porcine granulosa cells. 2007 Apr 3
6 17572486 Examination of Glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. 2007 Oct 1
7 12737312 RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance. 2003 Mar 6
8 10329417 Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486. 1999 May 19 1
9 9110922 Effects of progesterone and leukotriene receptor antagonists in experimental models of P-glycoprotein-related resistance. 1997 Apr 21 3
10 8913436 Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone. 1996 Aug 6
11 7654329 Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid-induced apoptosis. 1994 Nov-Dec 1
12 7982498 The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function. 1994 Nov 28 8